The use of real-world data to enhance clinical trials and regulatory submissions is gaining more acceptance around the world. Both regulators and payers increasingly ask for real world evidence to help understand the context of new therapies and the likely clinical and economic impact.
Real-World Data (RWD) is defined as data which has been collected from a number of sources that are associated with outcomes from a diverse range of participants in a real-world setting.


